Smart Insulin Management Devices Market Size, Share, Industry, Forecast and Outlook (2023-2030)

<h2>Global Smart Insulin Management Devices Market is Segmented By Product Type (Insulin Pen Injectors, Insulin jet injectors, Insulin Pumps (External Insulin pumps, Implantable pumps), Insulin patches, Insulin inhalers), By Disease Type (Diabetes Type I, Diabetes Type II, Gestational Diabetes), By End User (Hospitals, Home Care settings, Specialty Clinics, Others), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) &ndash; Share, Size, Outlook, and Opportunity Analysis, 2023-2030</h2>

<h3>Smart Insulin Management Devices Market Overview</h3>

<blockquote>
Global Smart Insulin Management Devices Market reached US$ YY&nbsp;million in 2022 and is expected to reach US$ YY&nbsp; million by 2030 growing at a CAGR of YY% during the forecast period 2023-2030.&nbsp;
</blockquote>

Smart insulin management devices are used for managing diabetes which includes type 1, type 2, and gestational diabetes. These devices are technologically advanced and can be connected to multiple devices like glucose monitors, and smart pens with meal detection technology all at once so that the efficiency increases. Few of the devices are reusable and can be connected to a smartphone app so that continuous monitoring of blood sugar levels won&#39;t be difficult.

The increase in awareness about health among people along with the easy usage of the devices increased the overall usage by people, especially the geriatric population. The prevalence of diabetes worldwide is high for instance, according to the National Institute of Health, by 2030, 643 million people will have diabetes globally, increasing to 783 million by 2045.

<h3>Smart Insulin Management Devices Market Scope</h3>

<table cellspacing="0" style="border-collapse:collapse">
	<tbody>
		<tr>
			<td style="background-color:#4472c4; border-bottom:1px solid #4472c4; border-left:1px solid #4472c4; border-top:1px solid #4472c4; vertical-align:top; width:312px">
			Metrics
			</td>
			<td style="background-color:#4472c4; border-bottom:1px solid #4472c4; border-right:1px solid #4472c4; border-top:1px solid #4472c4; vertical-align:top; width:312px">
			Details
			</td>
		</tr>
		<tr>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-top:1px solid #4472c4; vertical-align:middle; width:312px">
			CAGR
			</td>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #4472c4; vertical-align:middle; width:312px">
			YY%
			</td>
		</tr>
		<tr>
			<td style="border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Market Size
			</td>
			<td style="border-bottom:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			2021-2030
			</td>
		</tr>
		<tr>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Market Estimation Forecast Period
			</td>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			2023-2030
			</td>
		</tr>
		<tr>
			<td style="border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Revenue Units
			</td>
			<td style="border-bottom:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Value (US$ Mn)
			</td>
		</tr>
		<tr>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Segments Covered
			</td>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Product Type, Disease Type, End User
			</td>
		</tr>
		<tr>
			<td style="border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Regions Covered
			</td>
			<td style="border-bottom:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			North America, Europe, Asia-Pacific, South America, and Middle East &amp; Africa
			</td>
		</tr>
		<tr>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Largest Region
			</td>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			North America
			</td>
		</tr>
		<tr>
			<td style="border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Fastest Growing Region
			</td>
			<td style="border-bottom:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Asia-Pacific
			</td>
		</tr>
		<tr>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Report Insights Covered
			</td>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and Acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, Porter&rsquo;s Analysis, Pricing Analysis, Regulatory Analysis, Supply-Chain Analysis, and Other key Insights.
			</td>
		</tr>
	</tbody>
</table>

&nbsp;

For more details on this report &ndash; <a href="https://www.datamintelligence.com/download-sample/smart-insulin-management-devices-market" target="_blank">Request for Sample</a>&nbsp;

&nbsp;

<h3>Market Dynamics: Drivers &amp; Restraints</h3>

Increasing strategic developments by the companies

The number of strategic developments by the companies increased due to the increase in awareness about diabetes and its aftereffects. People are becoming self-aware about health hence the usage of smart insulin pens increased combined with technological advancements.&nbsp;

For instance, in March 2023, Diabeloop, a pioneer in Automated Insulin Delivery, will collaborate with a leading global healthcare company, Novo Nordisk. The agreement covers integrating DBL-4penTM, Diabeloop&rsquo;s self-learning algorithm for MDI therapy, with Novo Nordisk&rsquo;s connected and reusable insulin pens, NovoPen 6, and NovoPen Echo Plus. Diabeloop is planning a dedicated study for people living with Type 2 diabetes to evaluate the efficacy and clinical benefits of the combined technologies.

Furthermore, in September 2023, Abbott and Bigfoot Biomedical entered into a definitive agreement for Abbott to acquire Bigfoot, a leader in developing smart insulin management systems for people with diabetes.

In May 2023, Medtronic plc entered into a set of definitive agreements to acquire EOFlow Co. Ltd, manufacturer of the EOPatch device, a tubeless, wearable, and fully disposable insulin delivery device.

Complications associated with insulin devices

Management of diabetes using insulin devices causes complications due to the lack of proper usage and device failures. According to the Juvenile Diabetes Research Foundation Ltd, 2023 article, insulin pumps increase the chances of ketoacidosis which can increase the glucose level and cause severe other complications. The risk of transmitting bloodborne infections is higher with insulin pen needles which cause needle stick injuries. Abscess formation, lipohypertrophy, and lipoatrophy are also seen with insulin pens and injectors.

<h3>Smart Insulin Management Devices Market Segmentation</h3>

The global smart insulin management devices are segmented based on product type, disease type, end user and region.

The Insulin Pumps segment accounted for approximately 56.7% of the market share&nbsp;

Insulin pumps are expected to hold the largest share of the market due to the increased launch of smart insulin pumps. For instance, in April 2023, Medtronic plc, the global leader in medical technology, stated the U.S. Food and Drug Administration (FDA) approval of its MiniMed 780G system with the Guardian 4 sensor requiring no fingersticks while in SmartGuard technology. It is the world&#39;s first insulin pump with meal-detection technology.

Furthermore, in May 2023, Beta Bionics Inc. received Food and Drug Administration clearance for iLet ACE Pump and iLet Dosing Decision Software. The two devices along with an integrated continuous glucose monitor (iCGM), will form a new system called the iLet Bionic Pancreas. This new automated insulin dosing (AID) system uses an algorithm to determine and command insulin delivery. It is useful for people six years of age and older with type 1 diabetes.

<h3>Global Smart Insulin Management Devices Market Geographical Share</h3>

North America accounted for approximately 43.5% of the market share in 2022

According to National Institute of Diabetes and Kidney Diseases, 2023, approximately 2% to 10% of pregnancies in the United States are affected by gestational diabetes annually. More than 50% of women develop diabetes during their pregnancies.&nbsp;

The overall cost of diagnosing diabetes is also high in the US. For instance, according to Centers for Disease Control and Prevention, 2023, the total estimated cost of diagnosed diabetes in 2022 was $413 billion, including $307 billion in direct medical costs and $106 billion in indirect costs attributable to diabetes. Excess medical costs associated with diabetes were about $12,000 per person in 2022.

<h3>COVID-19 Impact Analysis</h3>

COVID-19 has impacted positively the smart insulin management devices market. There is an increased risk of contracting COVID-19 with underlying co-morbidities such as diabetes and hypertension. This shifted the focus of managing diabetes with care and caution. Due to the fear of contracting the infection, many people started to manage diabetes with the help of insulin devices like pumps, injectors, pens, etc.&nbsp;&nbsp;

<h3>Competitive Landscape</h3>

The major global players in the smart insulin management devices market include Sanofi S.A., Abbott Laboratories, Medtronic plc, Eli Lilly and Company, F. Hoffmann-La Roche Ltd, i-SENS, Inc., Novo Nordisk A/S, Ypsomed Holding AG, Diabeloop SA., Tandem Diabetes Care, Inc. among others.

<h3>Key Developments</h3>

<ul>
	<li>In September 2023, Medtronic won the CE mark for the next-gen Simplera (CGM) continuous glucose monitor with InPen integration.</li>
	<li>In September 2022, Medtronic Plc launched the Smart MDI system which provides smart insulin dosing by combining the InPen smart insulin pen with the Guardian 4 smart continuous glucose monitoring (CGM) system.</li>
</ul>

Why Purchase the Report?

<ul>
	<li>To visualize the global smart insulin management devices market segmentation based on product type, disease type, end-user and region as well as understand key commercial assets and players.</li>
	<li>Identify commercial opportunities by analyzing trends and co-development.&nbsp;</li>
	<li>Excel data sheet with numerous data points of smart insulin management devices market-level with all segments.</li>
	<li>PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.</li>
	<li>Product mapping available as excel consisting of key products of all the major players.</li>
</ul>

The global smart insulin management devices market report would provide approximately 58 tables, 60 figures, and 195 Pages.

<h3>Target Audience 2023</h3>

<ul>
	<li>Manufacturers/ Buyers</li>
	<li>Industry Investors/Investment Bankers</li>
	<li>Research Professionals</li>
	<li>Emerging Companies</li>
</ul>

<ol>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Methodology and Scope</h3>

	<ol>
		<li>Research Methodology</li>
		<li>Research Objective and Scope of the Report</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Definition and Overview</h3>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Executive Summary</h3>

	<ol>
		<li>Snippet by Product Type</li>
		<li>Snippet by Disease Type</li>
		<li>Snippet by End User</li>
		<li>Snippet by Region</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Dynamics</h3>

	<ol>
		<li>Impacting Factors
		<ol>
			<li>Driver
			<ol>
				<li>Increasing strategic developments by the companies</li>
				<li>XX</li>
			</ol>
			</li>
			<li>Restraints
			<ol>
				<li>Complications associated with insulin devices</li>
				<li>XX</li>
			</ol>
			</li>
			<li>Opportunity</li>
			<li>Impact Analysis</li>
		</ol>
		</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Industry Analysis&nbsp;</h3>

	<ol>
		<li>Porter&#39;s Five Force Analysis&nbsp;</li>
		<li>Supply Chain Analysis</li>
		<li>Pricing Analysis</li>
		<li>Regulatory Analysis</li>
		<li>DMI Opinion</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">COVID-19 Analysis</h3>

	<ol>
		<li>Analysis of COVID-19
		<ol>
			<li>Scenario Before COVID</li>
			<li>Scenario During COVID</li>
			<li>Scenario Post COVID</li>
		</ol>
		</li>
		<li>Pricing Dynamics Amid COVID-19</li>
		<li>Demand-Supply Spectrum</li>
		<li>Government Initiatives Related to the Market During Pandemic</li>
		<li>Manufacturers Strategic Initiatives</li>
		<li>Conclusion</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">By Product Type</h3>

	<ol>
		<li>Introduction
		<ol>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type</li>
			<li>Market Attractiveness Index, By Product Type</li>
		</ol>
		</li>
		<li>Insulin Pen Injectors*
		<ol>
			<li>Introduction</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%)</li>
		</ol>
		</li>
		<li>Insulin jet injectors</li>
		<li>Insulin pumps
		<ol>
			<li>External Insulin pumps</li>
			<li>Implantable pumps</li>
		</ol>
		</li>
		<li>Insulin patches</li>
		<li>Insulin inhalers</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">By Disease Type</h3>

	<ol>
		<li>Introduction
		<ol>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease Type</li>
			<li>Market Attractiveness Index, By Disease Type</li>
		</ol>
		</li>
		<li>&nbsp;Diabetes Type I*
		<ol>
			<li>Introduction</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%)</li>
		</ol>
		</li>
		<li>Diabetes Type II&nbsp;</li>
		<li>Gestational Diabetes&nbsp;</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">By End User</h3>

	<ol>
		<li>Introduction
		<ol>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By End User</li>
			<li>Market Attractiveness Index, By End User</li>
		</ol>
		</li>
		<li>&nbsp;Hospitals*
		<ol>
			<li>Introduction</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%)</li>
		</ol>
		</li>
		<li>Specialty Clinics</li>
		<li>Home Care settings</li>
		<li>Others</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">By Region</h3>

	<ol>
		<li>Introduction
		<ol>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Region</li>
			<li>Market Attractiveness Index, By Region</li>
		</ol>
		</li>
		<li>North America
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease Type</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By End User</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
			<ol>
				<li>U.S.</li>
				<li>Canada</li>
				<li>Mexico</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>Europe
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease Type</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By End User</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
			<ol>
				<li>Germany</li>
				<li>UK</li>
				<li>France</li>
				<li>Italy</li>
				<li>Spain</li>
				<li>Rest of Europe</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>South America
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease Type</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By End User</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
			<ol>
				<li>Brazil</li>
				<li>Argentina</li>
				<li>Rest of South America</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>Asia-Pacific
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease Type</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By End User</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
			<ol>
				<li>China</li>
				<li>India</li>
				<li>Japan</li>
				<li>Australia</li>
				<li>Rest of Asia-Pacific</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>Middle East and Africa
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease Type</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By End User</li>
		</ol>
		</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Competitive Landscape</h3>

	<ol>
		<li>Competitive Scenario</li>
		<li>Market Positioning/Share Analysis</li>
		<li>Mergers and Acquisitions Analysis</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Company Profiles</h3>

	<ol>
		<li>Sanofi S.A.&nbsp;&nbsp;&nbsp;
		<ol>
			<li>Company Overview</li>
			<li>Product Type Portfolio and Description</li>
			<li>Financial Overview</li>
			<li>Key Developments</li>
		</ol>
		</li>
		<li>Abbott Laboratories</li>
		<li>Medtronic plc</li>
		<li>Eli Lilly and Company</li>
		<li>F. Hoffmann-La Roche Ltd</li>
		<li>i-SENS, Inc.</li>
		<li>Novo Nordisk A/S</li>
		<li>Ypsomed Holding AG</li>
		<li>Diabeloop SA.</li>
		<li>Tandem Diabetes Care, Inc.&nbsp;(*LIST NOT EXHAUSTIVE)&nbsp;</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Appendix</h3>

	<ol>
		<li>About Us and Services</li>
		<li>Contact Us</li>
	</ol>
	</li>
</ol>

&nbsp;

<ul>
</ul>

List of Tables

Table 1 Global Smart Insulin Management Devices Market Value, By Product Type, 2022, 2026 &amp; 2030 (US$ Million)

Table 2 Global Smart Insulin Management Devices Market Value, By Disease Type, 2022, 2026 &amp; 2030 (US$ Million)

Table 3 Global Smart Insulin Management Devices Market Value, By End-User, 2022, 2026 &amp; 2030 (US$ Million)

Table 4 Global Smart Insulin Management Devices Market Value, By Region, 2022, 2026 &amp; 2030 (US$ Million)

Table 5 Global Smart Insulin Management Devices Market Value, By Product Type, 2021-2030 (US$ Million)

Table 6 Global Smart Insulin Management Devices Market Value, By Disease Type, 2021-2030 (US$ Million)

Table 7 Global Smart Insulin Management Devices Market Value, By End-User, 2021-2030 (US$ Million)

Table 8 Global Smart Insulin Management Devices Market Value, By Region, 2022, 2026 &amp; 2030 (US$ Million)

Table 9 Global Smart Insulin Management Devices Market Value, By Region, 2021-2030 (US$ Million)

Table 10 North America Smart Insulin Management Devices Market Value, By Product Type, 2021-2030 (US$ Million)

Table 11 North America Smart Insulin Management Devices Market Value, By Disease Type, 2021-2030 (US$ Million)

Table 12 North America Smart Insulin Management Devices Market Value, By End-User, 2021-2030 (US$ Million)

Table 13 North America Smart Insulin Management Devices Market Value, By Country, 2021-2030 (US$ Million)

Table 14 South America Smart Insulin Management Devices Market Value, By Product Type, 2021-2030 (US$ Million)

Table 15 South America Smart Insulin Management Devices Market Value, By Disease Type, 2021-2030 (US$ Million)

Table 16 South America Smart Insulin Management Devices Market Value, By End-User, 2021-2030 (US$ Million)

Table 17 South America Smart Insulin Management Devices Market Value, By Country, 2021-2030 (US$ Million)

Table 18 Europe Smart Insulin Management Devices Market Value, By Product Type, 2021-2030 (US$ Million)

Table 19 Europe Smart Insulin Management Devices Market Value, By Disease Type, 2021-2030 (US$ Million)

Table 20 Europe Smart Insulin Management Devices Market Value, By End-User, 2021-2030 (US$ Million)

Table 21 Europe Smart Insulin Management Devices Market Value, By Country, 2021-2030 (US$ Million)

Table 22 Asia-Pacific Smart Insulin Management Devices Market Value, By Product Type, 2021-2030 (US$ Million)

Table 23 Asia-Pacific Smart Insulin Management Devices Market Value, By Disease Type, 2021-2030 (US$ Million)

Table 24 Asia-Pacific Smart Insulin Management Devices Market Value, By End-User, 2021-2030 (US$ Million)

Table 25 Asia-Pacific Smart Insulin Management Devices Market Value, By Country, 2021-2030 (US$ Million)

Table 26 Middle East &amp; Africa Smart Insulin Management Devices Market Value, By Product Type, 2021-2030 (US$ Million)

Table 27 Middle East &amp; Africa Smart Insulin Management Devices Market Value, By Disease Type, 2021-2030 (US$ Million)

Table 28 Middle East &amp; Africa Smart Insulin Management Devices Market Value, By End-User, 2021-2030 (US$ Million)

Table 29 Sanofi S.A.: Overview

Table 30 Sanofi S.A.: Product Portfolio

Table 31 Sanofi S.A.: Key Developments

Table 32 Abbott Laboratories: Overview

Table 33 Abbott Laboratories: Product Portfolio

Table 34 Abbott Laboratories: Key Developments

Table 35 Medtronic plc: Overview

Table 36 Medtronic plc: Product Portfolio

Table 37 Medtronic plc: Key Developments

Table 38 Elly Lilly and Company: Overview

Table 39 Elly Lilly and Company: Product Portfolio

Table 40 Elly Lilly and Company: Key Developments

Table 41 F. Hoffmann-La Roche Ltd: Overview

Table 42 F. Hoffmann-La Roche Ltd: Product Portfolio

Table 43 F. Hoffmann-La Roche Ltd: Key Developments

Table 44 i-SENS, Inc.: Overview

Table 45 i-SENS, Inc.: Product Portfolio

Table 46 i-SENS, Inc.: Key Developments

Table 47 Novo Nordisk A/S: Overview

Table 48 Novo Nordisk A/S: Product Portfolio

Table 49 Novo Nordisk A/S: Key Developments

Table 50 Ypsomed Holding AG: Overview

Table 51 Ypsomed Holding AG: Product Portfolio

Table 52 Ypsomed Holding AG: Key Developments

Table 53 Diabeloop SA.: Overview

Table 54 Diabeloop SA.: Product Portfolio

Table 55 Diabeloop SA.: Key Developments

Table 56 Tandem Diabetes Care, Inc.: Overview

Table 57 Tandem Diabetes Care, Inc.: Product Portfolio

Table 58 Tandem Diabetes Care, Inc.: Key Developments

List of Figures

Figure 1 Global Smart Insulin Management Devices Market Value, 2021-2030 (US$ Million)

Figure 2 Global Smart Insulin Management Devices Market Share, By Product Type, 2022 &amp; 2030 (%)

Figure 3 Global Smart Insulin Management Devices Market Share, By Disease Type, 2022 &amp; 2030 (%)

Figure 4 Global Smart Insulin Management Devices Market Share, By End-User, 2022 &amp; 2030 (%)

Figure 5 Global Smart Insulin Management Devices Market Share, By Region, 2022 &amp; 2030 (%)

Figure 6 Global Smart Insulin Management Devices Market Y-o-Y Growth, By Product Type, 2022-2030 (%)

Figure 7 Insulin Pen Injectors Smart Insulin Management Devices Market Value, 2021-2030 (US$ Million)

Figure 8 Insulin jet injectors Smart Insulin Management Devices Market Value, 2021-2030 (US$ Million)

Figure 9 Insulin pumps Smart Insulin Management Devices Market Value, 2021-2030 (US$ Million)

Figure 10 Insulin patches Smart Insulin Management Devices Market Value, 2021-2030 (US$ Million)

Figure 11 Insulin inhalers Smart Insulin Management Devices Market Value, 2021-2030 (US$ Million)

Figure 12 Global Smart Insulin Management Devices Market Y-o-Y Growth, By Disease Type, 2022-2030 (%)

Figure 13 Diabetes Type I Disease Type in Global Smart Insulin Management Devices Market Value, 2021-2030 (US$ Million)

Figure 14 Diabetes Type II Disease Type in Global Smart Insulin Management Devices Market Value, 2021-2030 (US$ Million)

Figure 15 Gestational Diabetes Disease Type in Global Smart Insulin Management Devices Market Value, 2021-2030 (US$ Million)

Figure 16 Global Smart Insulin Management Devices Market Y-o-Y Growth, By End-User, 2022-2030 (%)

Figure 17 Hospitals in Global Smart Insulin Management Devices Market Value, 2021-2030 (US$ Million)

Figure 18 Specialty Clinics in Global Smart Insulin Management Devices Market Value, 2021-2030 (US$ Million)

Figure 19 Home Care settings in Global Smart Insulin Management Devices Market Value, 2021-2030 (US$ Million)

Figure 20 Others in Global Smart Insulin Management Devices Market Value, 2021-2030 (US$ Million)

Figure 21 Global Smart Insulin Management Devices Market Y-o-Y Growth, By Region, 2022-2030 (%)

Figure 22 North America Smart Insulin Management Devices Market Value, 2021-2030 (US$ Million)

Figure 23 Asia-Pacific Smart Insulin Management Devices Market Value, 2021-2030 (US$ Million)

Figure 24 Europe Smart Insulin Management Devices Market Value, 2021-2030 (US$ Million)

Figure 25 South America Smart Insulin Management Devices Market Value, 2021-2030 (US$ Million)

Figure 26 Middle East and Africa Smart Insulin Management Devices Market Value, 2021-2030 (US$ Million)

Figure 27 North America Smart Insulin Management Devices Market Value, 2021-2030 (US$ Million)

Figure 28 North America Smart Insulin Management Devices Market Share, By Product Type, 2022 &amp; 2030 (%)

Figure 29 North America Smart Insulin Management Devices Market Share, By Disease Type, 2022 &amp; 2030 (%)

Figure 30 North America Smart Insulin Management Devices Market Share, By End-User, 2022 &amp; 2030 (%)

Figure 31 North America Smart Insulin Management Devices Market Share, By Country, 2022 &amp; 2030 (%)

Figure 32 South America Smart Insulin Management Devices Market Value, 2021-2030 (US$ Million)

Figure 33 South America Smart Insulin Management Devices Market Share, By Product Type, 2022 &amp; 2030 (%)

Figure 34 South America Smart Insulin Management Devices Market Share, By Disease Type, 2022 &amp; 2030 (%)

Figure 35 South America Smart Insulin Management Devices Market Share, By End-User, 2022 &amp; 2030 (%)

Figure 36 South America Smart Insulin Management Devices Market Share, By Country, 2022 &amp; 2030 (%)

Figure 37 Europe Smart Insulin Management Devices Market Value, 2021-2030 (US$ Million)

Figure 38 Europe Smart Insulin Management Devices Market Share, By Product Type, 2022 &amp; 2030 (%)

Figure 39 Europe Smart Insulin Management Devices Market Share, By Disease Type, 2022 &amp; 2030 (%)

Figure 40 Europe Smart Insulin Management Devices Market Share, By End-User, 2022 &amp; 2030 (%)

Figure 41 Europe Smart Insulin Management Devices Market Share, By Country, 2022 &amp; 2030 (%)

Figure 42 Asia-Pacific Smart Insulin Management Devices Market Value, 2021-2030 (US$ Million)

Figure 43 Asia-Pacific Smart Insulin Management Devices Market Share, By Product Type, 2022 &amp; 2030 (%)

Figure 44 Asia-Pacific Smart Insulin Management Devices Market Share, By Disease Type, 2022 &amp; 2030 (%)

Figure 45 Asia-Pacific Smart Insulin Management Devices Market Share, By End-User, 2022 &amp; 2030 (%)

Figure 46 Asia-Pacific Smart Insulin Management Devices Market Share, By Country, 2022 &amp; 2030 (%)

Figure 47 Middle East &amp; Africa Smart Insulin Management Devices Market Value, 2021-2030 (US$ Million)

Figure 48 Middle East &amp; Africa Smart Insulin Management Devices Market Share, By Product Type, 2022 &amp; 2030 (%)

Figure 49 Middle East &amp; Africa Smart Insulin Management Devices Market Share, By Disease Type, 2022 &amp; 2030 (%)

Figure 50 Middle East &amp; Africa Smart Insulin Management Devices Market Share, By End-User, 2022 &amp; 2030 (%)

Figure 51 Sanofi S.A.: Financials

Figure 52 Abbott Laboratories: Financials

Figure 53 Medtronic plc: Financials

Figure 54 Elly Lilly and Company: Financials

Figure 55 F. Hoffmann-La Roche Ltd: Financials

Figure 56 i-SENS, Inc.: Financials

Figure 57 Novo Nordisk A/S: Financials

Figure 58 Ypsomed Holding AG: Financials

Figure 59 Diabeloop SA.: Financials

Figure 60 Tandem Diabetes Care, Inc.: Financials

&nbsp;

Smart Insulin Management Devices Market Size, Share, Industry, Forecast and Outlook (2023-2030)

Insulin Pen Market Size, Share, Industry, Forecast and outlook (2023-2030)

Published: 2023 October 13

Starting from

Glucose Monitoring Devices Market Size, Share, Industry, Forecast and outlook (2024-2031)

Published: 2024 May 13

Starting from

Insulin Delivery devices Market Size, Share, Industry, Forecast and outlook (2024-2031)

Published: 2024 April 01

Starting from

Insulin Infusion Pumps Market Size, Share, Industry, Forecast and Outlook (2023-2030)

Published: 2023 November 30

Starting from